Citadel Advisors’s Veoneer, Inc. VNE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-11,200
Closed -$258K 15163
2021
Q2
$258K Sell
11,200
-10,200
-48% -$242K ﹤0.01% 11634
2021
Q1
$524K Sell
21,400
-9,500
-31% -$248K ﹤0.01% 9579
2020
Q4
$658K Buy
30,900
+14,700
+91% +$278K ﹤0.01% 7625
2020
Q3
$238K Buy
+16,200
New +$195K ﹤0.01% 8542
2020
Q2
Sell
-10,000
Closed -$73K 10776
2020
Q1
$73K Sell
10,000
-6,600
-40% -$78.7K ﹤0.01% 8836
2019
Q4
$259K Sell
16,600
-16,300
-50% -$262K ﹤0.01% 7813
2019
Q3
$493K Buy
32,900
+4,600
+16% +$74.7K ﹤0.01% 6779
2019
Q2
$490K Buy
+28,300
New +$593K ﹤0.01% 6847

Other funds holding VNE

Citadel Advisors's VNE Position: Q1 2022 in Review

Citadel Advisors sold out of Veoneer, Inc. (VNE) in Q1 2022, closing a stake of 134,222 shares — an estimated $4.76M sold.

Citadel Advisors first reported a position in VNE in Q4 2018 and held it in 13 quarters. The position peaked at $42.8M in Q2 2019. 143 funds tracked by Wall St. Rank hold VNE as of Q1 2022.

  • Citadel Advisors reported no remaining Veoneer, Inc. position as of Q1 2022 after selling out during the quarter.
  • Citadel Advisors sold 134,222 Veoneer, Inc. shares in Q1 2022, an estimated $4.76M.
  • Citadel Advisors first reported a position in Veoneer, Inc. in Q4 2018 and held it in 13 quarters.
  • Citadel Advisors's Veoneer, Inc. position peaked at $42.8M in Q2 2019.
  • 143 funds tracked by Wall St. Rank held Veoneer, Inc. as of Q1 2022.

Based on Citadel Advisors's 13F filing for Q1 2022, filed 16 May 2022.